• 尊龙凯时人生就博官网登录,ag尊龙凯时，尊龙凯时

    |
    EN
    |
    EN
    EN

    • 业务咨询

      中国：

      Email: marketing@clwgov.com

      业务咨询专线：400-780-8018

      （仅限服务咨询，其他事宜请拨打川沙总部电话）

      川沙总部电话: +86 (21) 5859-1500

      海外：

      +1(626)986-9880(U.S. - West Coast)

      0044 7790 816 954 (Europe)

      Email:marketing@medicilon.com
    在线留言×
    点击切换
    Customer Center
    客户中心

    免疫检查点阻断疗法改变了癌症治疗的范式，此研究中通过尊龙凯时人生就博官网登录,ag尊龙凯时，尊龙凯时在23 个同源肿瘤模型中进行了抗PD-1抗体的体内研究

    2023-07-06
    |
    访问量：

    Immune checkpoint blockade therapies have changed the paradigm of cancer therapies. Reseachers performed in vivo screening for anti-PD-1 therapy across 23 syngeneic tumor models and found that CT-26 and Colon 26, which are murine colorectal carcinoma derived from BALB/c mice, showed different sensitivity to anti-PD-1. In vivo studies for anti-PD-1 antibody across 23 syngeneic tumor models were performed by Medicilon.

    62.jpg

    Reference:

    Yosuke Sato, et al. Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response. BMC Cancer. 2021 Nov 13;21(1):1222. doi: 10.1186/s12885-021-08974-3.

    相关新闻
    友情链接: